# Redbud Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/redbud-medicine

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.redbudmed.com
- Total disclosed funding: $10M
- Latest round: Series A (Aug 23, 2022)
- Investors on record: 3

## About

Based in Beijing, China, and founded in 2019, Redbud Medicine is a clinical CRO company dedicated to providing clinical development solutions for pharmaceutical companies. It has global clinical operation teams in US and China, with subsidiaries in Beijing, Shanghai, and Ningbo. Its founder was formerly a senior global clinical development leader at MNC.

The company's business can be categorized into regulatory affairs, clinical research development and medical affairs, clinical operation, data management, and statistic analysis service. It helps domestic pharmaceutical start-ups to do clinical work overseas and transform clients into strategic partners.

## Funding rounds

- Series A, Aug 23, 2022, $10M — Delian Capital, Ming Bioventures, Hongfeng Venture

## Investors

- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series A
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Series A
- Hongfeng Venture (https://capitalatlas.ai/funds/hongfeng-venture) — Series A